Structure of CC-1065 (NSC-298223), a new antitumor antibiotic.

Suppr

超能文献

作者信息

Martin D G, Chidester C G, Duchamp D J, Mizsak S A

出版信息

J Antibiot (Tokyo). 1980 Aug;33(8):902-3. doi: 10.7164/antibiotics.33.902.

DOI:10.7164/antibiotics.33.902

PMID:7429992

Abstract

摘要

相似文献

Structure of CC-1065 (NSC-298223), a new antitumor antibiotic.

J Antibiot (Tokyo). 1980 Aug;33(8):902-3. doi: 10.7164/antibiotics.33.902.

Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity.

Science. 1984 Nov 16;226(4676):843-4. doi: 10.1126/science.6494915.

CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity.CC-1065（NSC 298223），一种强效新型抗肿瘤药物，改进了生产、分离、表征及抗肿瘤活性。

J Antibiot (Tokyo). 1981 Sep;34(9):1119-25. doi: 10.7164/antibiotics.34.1119.

Potential antitumor agents. I. Synthesis of pyrroloindazole derivatives related to the pyrroloindole moieties of the antitumor antibiotic CC-1065.

Farmaco Sci. 1987 Aug;42(8):567-74.

Binding of CC-1065 to poly- and oligonucleotides.CC-1065与多核苷酸和寡核苷酸的结合。

Biopolymers. 1985 Aug;24(8):1549-72. doi: 10.1002/bip.360240811.

Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065.

J Med Chem. 1988 Mar;31(3):590-603. doi: 10.1021/jm00398a017.

Biosynthesis of the antitumor antibiotic CC-1065 by Streptomyces zelensis.

J Antibiot (Tokyo). 1983 Apr;36(4):383-90. doi: 10.7164/antibiotics.36.383.

[Synthesis of the antitumor antibiotic CC-1065 by a Streptomyces canulus 106/78 culture].

Antibiotiki. 1982 May;27(5):323-6.

Mechanism of interaction of CC-1065 (NSC 298223) with DNA.CC-1065（NSC 298223）与DNA的相互作用机制。

Cancer Res. 1982 Jul;42(7):2821-8.

CC-1065 transformations.CC - 1065转化

J Antibiot (Tokyo). 1985 Jun;38(6):746-52. doi: 10.7164/antibiotics.38.746.

引用本文的文献

Synthesis of N-Substituted Pyrrole-2,5-Dicarboxylic Acids from d-Galactaric Acid.由d-半乳糖二酸合成N-取代的吡咯-2,5-二羧酸

ChemSusChem. 2025 Oct 1;18(19):e202501106. doi: 10.1002/cssc.202501106. Epub 2025 Aug 18.

Biosynthesis of DNA-Alkylating Antitumor Natural Products.DNA 烷化抗肿瘤天然产物的生物合成。

Molecules. 2022 Sep 27;27(19):6387. doi: 10.3390/molecules27196387.

A radical S-adenosyl-L-methionine enzyme and a methyltransferase catalyze cyclopropane formation in natural product biosynthesis.一种激进的 S-腺苷-L-蛋氨酸酶和一种甲基转移酶在天然产物生物合成中催化环丙烷的形成。

Nat Commun. 2018 Jul 17;9(1):2771. doi: 10.1038/s41467-018-05217-1.

Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models.普罗西马布-多卡霉素，一种新型的CD56抗体-药物偶联物，在小细胞肺癌异种移植模型中具有高效性。

Oncotarget. 2017 Dec 26;9(4):5197-5207. doi: 10.18632/oncotarget.23708. eCollection 2018 Jan 12.

Synthesis and cytotoxicity of a biotinylated CC-1065 analogue.一种生物素化的CC-1065类似物的合成与细胞毒性

BMC Chem Biol. 2002;2(1):1. doi: 10.1186/1472-6769-2-1.

Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug.一种头孢菌素-CC-1065类似物前药的合成及初步细胞毒性研究。

BMC Chem Biol. 2001;1(1):4. doi: 10.1186/1472-6769-1-4.

Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.

Invest New Drugs. 1996;13(4):321-6. doi: 10.1007/BF00873138.

Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.比泽司汀（一种强效双功能DNA结合抗生素CC - 1065类似物）的临床前药理学

Cancer Chemother Pharmacol. 1994;34(4):317-22. doi: 10.1007/BF00686039.

Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.几种抗肿瘤药物及其他药剂与强效烷基化剂阿多来新的协同和相加组合。

Cancer Chemother Pharmacol. 1995;35(6):471-82. doi: 10.1007/BF00686831.

V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant.

Cancer Chemother Pharmacol. 1994;34(1):44-50. doi: 10.1007/BF00686110.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验